Raymond James & Associates Zomedica Corp. Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$0.28 - $0.4 $3,670 - $5,244	-13,110 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$0.31 - $0.58 $62 - $115	200 Added 1.55%	13,110 $4,000
Q3 2021 Nov 02, 2021	SELL	$0.46 - $0.81 $1,058 - $1,863	-2,300 Reduced 15.12%	12,910 $7,000
Q2 2021 Aug 11, 2021	SELL	$0.72 - $1.46 $1,525 - $3,093	-2,119 Reduced 12.23%	15,210 $13,000
Q1 2021 May 14, 2021	SELL	$0.35 - $2.7 $1,349 - $10,413	-3,857 Reduced 18.21%	17,329 $27,000
Q4 2020 Feb 12, 2021	BUY	$0.07 - $0.25 $1,483 - $5,296	21,186 New	21,186 $5,000

80.9M

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.